Is a 9.5 mm left-sided lower calyceal stone indicated for Extracorporeal Shock Wave Lithotripsy (ESWL)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

A 9.5 mm left-sided lower calyceal stone is not the ideal candidate for Extracorporeal Shock Wave Lithotripsy (ESWL) due to its size and location, and ureteroscopy with laser lithotripsy is generally preferred as the first-line treatment. According to the EAU guidelines, active surveillance is acceptable for stones up to 15 mm, but for lower pole stones between 10 and 20 mm, fURS and PCNL are suggested options 1. Although SIU/ICUD guidelines recommend treating lower pole renal stones with SWL as the first choice for stones less than 15 mm, the success rate of ESWL for lower calyceal stones is reduced due to gravity-dependent position and challenging fragment passage.

Some key points to consider when evaluating the suitability of ESWL for this patient include:

  • Stone size: The 9.5 mm stone size reduces ESWL success rates, as stones larger than 1 cm generally respond less favorably to shock wave therapy.
  • Stone location: Lower calyceal stones have reduced clearance rates with ESWL compared to stones in other locations.
  • Patient-specific factors: Skin-to-stone distance, stone density, and lower pole anatomy further influence success rates. If ESWL is still pursued, patients should be informed about the lower success rate and potential need for additional procedures, and post-procedure recommendations would include adequate hydration, possible alpha-blockers, and appropriate pain management 1.

From the Research

Indications for ESWL

  • A 9.5 mm left-sided lower calyceal stone may be indicated for Extracorporeal Shock Wave Lithotripsy (ESWL) based on stone size and location.
  • Studies have shown that ESWL is effective for smaller stones, typically less than 2 cm in size 2, 3, 4.
  • However, the success rate of ESWL for lower pole stones is generally lower compared to other locations, such as the upper or middle calyces 2, 3.

Comparison with Other Treatments

  • Percutaneous nephrolithotomy (PCNL) and retrograde intrarenal surgery (RIRS) are alternative treatments for kidney stones, particularly for larger stones or those in difficult locations 5, 2, 3, 4.
  • PCNL has been shown to have a higher stone-free rate and efficiency quotient (EQ) compared to ESWL for lower pole stones, but may have a higher complication rate 2, 3.
  • RIRS, also known as flexible ureteroscopy, has been shown to have comparable stone-free rates to PCNL and higher than ESWL for lower pole stones, with potentially lower complication rates 4.

Specific Study Findings

  • A study comparing ESWL to PCNL for lower pole stones found that PCNL had a higher stone-free rate (83% vs 51%) and EQ (76% vs 44%) 3.
  • Another study comparing ESWL to RIRS and mini PCNL for lower pole stones found that RIRS and mini PCNL had higher stone-free rates (90.2% and 90.5%, respectively) compared to ESWL (61.5%) 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.